Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsTicagrelor Intermediates

C9H9F2N HCl Ticagrelor Intermediates CAS 1156491 10 9 cGMP standard

I'm Online Chat Now

C9H9F2N HCl Ticagrelor Intermediates CAS 1156491 10 9 cGMP standard

China C9H9F2N HCl Ticagrelor Intermediates CAS 1156491 10 9  cGMP standard supplier

Large Image :  C9H9F2N HCl Ticagrelor Intermediates CAS 1156491 10 9 cGMP standard

Product Details:

Place of Origin: China
Certification: Meet with cGMP standard

Payment & Shipping Terms:

Minimum Order Quantity: 1KG
Packaging Details: Drum
Contact Now
Detailed Product Description
Usage: Ticagrelor Intermediate CAS: 1156491-10-9
Molecular Formula: C9H10ClF2N
High Light:

145783 14 8

,

1156491 10 9

CAS : 1156491-10-9 Ticagrelor Intermediate C9H9F2N HCl cGMP standard

 

Chemical Name : Cyclopropanamine , 2 - ( 3 , 4 - difluorophenyl ) - , Hydrochloride ( 1 : 1 ) ; ( 1R , 2S ) - REL - , ( 1R , trans ) - 2 - ( 3 , 4 -difluorophenyl ) cyclopropane amine

 

Molecular Formula : C9H10ClF2N

 

Molecular Weight : 205.63

 

Usage : Ticagrelor Intermediate

 

 

Description :

 

Ticagrelor is the active pharmaceutical ingredient of Brilinta, Brilique or Possia, which is used to prevent thrombotic events such as heart attack or stroke in people who has acute coronary syndrome or myocardial infarction with ST elevation. It is produced by AstraZeneca. On Dec 30, 2010, it was approved by Europe Commission and on July 20, 2011 approved by US FDA. The global anual sales of Brilinta/Brilique is more than USD1 billion.

 

4 , 6 - Dichloro - 5 - Nitro - 2 - propylthiopyrimidine CAS No . : 145783-14-8 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries including Europe, USA and China. We strictly obey the laws and our commercial products are manufactured without infringing such patents. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.

 

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)